87 related articles for article (PubMed ID: 24357459)
1. A deletion causing NF2 exon 9 skipping is associated with familial autosomal dominant intramedullary ependymoma.
Zemmoura I; Vourc'h P; Paubel A; Parfait B; Cohen J; Bilan F; Kitzis A; Rousselot C; Parker F; François P; Andres CR
Neuro Oncol; 2014 Jan; 16(2):250-5. PubMed ID: 24357459
[TBL] [Abstract][Full Text] [Related]
2. Transcriptomic and epigenetic dissection of spinal ependymoma (SP-EPN) identifies clinically relevant subtypes enriched for tumors with and without NF2 mutation.
Neyazi S; Yamazawa E; Hack K; Tanaka S; Nagae G; Kresbach C; Umeda T; Eckhardt A; Tatsuno K; Pohl L; Hana T; Bockmayr M; Kim P; Dorostkar MM; Takami T; Obrecht D; Takai K; Suwala AK; Komori T; Godbole S; Wefers AK; Otani R; Neumann JE; Higuchi F; Schweizer L; Nakanishi Y; Monoranu CM; Takami H; Engertsberger L; Yamada K; Ruf V; Nomura M; Mohme T; Mukasa A; Herms J; Takayanagi S; Mynarek M; Matsuura R; Lamszus K; Ishii K; Kluwe L; Imai H; von Deimling A; Koike T; Benesch M; Kushihara Y; Snuderl M; Nambu S; Frank S; Omura T; Hagel C; Kugasawa K; Mautner VF; Ichimura K; Rutkowski S; Aburatani H; Saito N; Schüller U
Acta Neuropathol; 2024 Jan; 147(1):22. PubMed ID: 38265489
[TBL] [Abstract][Full Text] [Related]
3. MYCN immunohistochemistry as surrogate marker for MYCN-amplified spinal ependymomas.
Mohan D; Nambirajan A; Malik R; Sharma A; Suri V; Kaur K; Doddamani R; Garg A; Gupta S; Mallick S; Sharma MC
Hum Cell; 2024 May; 37(3):704-713. PubMed ID: 38411836
[TBL] [Abstract][Full Text] [Related]
4. Clinically aggressive pediatric spinal ependymoma with novel MYC amplification demonstrates molecular and histopathologic similarity to newly described MYCN-amplified spinal ependymomas.
Shatara M; Schieffer KM; Klawinski D; Thomas DL; Pierson CR; Sribnick EA; Jones J; Rodriguez DP; Deeg C; Hamelberg E; LaHaye S; Miller KE; Fitch J; Kelly B; Leraas K; Pfau R; White P; Magrini V; Wilson RK; Mardis ER; Abdelbaki MS; Finlay JL; Boué DR; Cottrell CE; Ghasemi DR; Pajtler KW; Osorio DS
Acta Neuropathol Commun; 2021 Dec; 9(1):192. PubMed ID: 34895332
[TBL] [Abstract][Full Text] [Related]
5. Pediatric spinal ependymoma with chromothripsis of chromosome 6: a case report and review of the literature.
Scott KR; Gener MA; Repnikova EA
J Med Case Rep; 2024 Feb; 18(1):95. PubMed ID: 38351155
[TBL] [Abstract][Full Text] [Related]
6. Missense variant interaction scanning reveals a critical role of the FERM domain for tumor suppressor protein NF2 conformation and function.
Moesslacher CS; Auernig E; Woodsmith J; Feichtner A; Jany-Luig E; Jehle S; Worseck JM; Heine CL; Stefan E; Stelzl U
Life Sci Alliance; 2023 Aug; 6(8):. PubMed ID: 37280085
[TBL] [Abstract][Full Text] [Related]
7. Prediction and evaluation of deleterious and disease causing non-synonymous SNPs (nsSNPs) in human NF2 gene responsible for neurofibromatosis type 2 (NF2).
Havranek B; Islam SM
J Biomol Struct Dyn; 2021 Nov; 39(18):7044-7055. PubMed ID: 32787631
[TBL] [Abstract][Full Text] [Related]
8. A novel NF2 splicing mutant causes neurofibromatosis type 2 via liquid-liquid phase separation with large tumor suppressor and Hippo pathway.
Jia Z; Yang S; Li M; Lei Z; Ding X; Fan M; Wang D; Xie D; Zhou H; Qiu Y; Zhuang Q; Li D; Yang W; Qi X; Cang X; Zhao JW; Wang W; Lin A; Yan Q
iScience; 2022 Nov; 25(11):105275. PubMed ID: 36300003
[TBL] [Abstract][Full Text] [Related]
9. Two cases of spinal tanycytic ependymomas occurring in brothers with a neurofibromatosis type 2 gene mutation.
Hall S; Sadek AR; Side L; Walker M; Nader-Sepahi A
Clin Neurol Neurosurg; 2022 Jul; 218():107303. PubMed ID: 35605508
[TBL] [Abstract][Full Text] [Related]
10. MYCN amplification in spinal ependymoma: A five-year retrospective study.
Rao S; Sugur H; Konar S; Arivazhagan A; Santosh V
Neuropathology; 2023 Dec; 43(6):457-462. PubMed ID: 37221449
[TBL] [Abstract][Full Text] [Related]
11. Antisense oligonucleotides targeting exon 11 are able to partially rescue the NF2-related schwannomatosis phenotype
Catasús N; Rosas I; Bonache S; Negro A; Torres-Martin M; Plana-Pla A; Salvador H; Serra E; Blanco I; Castellanos E;
Mol Ther Nucleic Acids; 2022 Dec; 30():493-505. PubMed ID: 36420221
[TBL] [Abstract][Full Text] [Related]
12. Case report of selumetinib as a novel therapy in a neurofibromatosis type 2-associated ependymoma.
Blackwood N; Zetzmann C; Trevino CR
Mol Ther Methods Clin Dev; 2023 Dec; 31():101156. PubMed ID: 38058737
[TBL] [Abstract][Full Text] [Related]
13. Anaplastic histology and distinct molecular features in a small series of spinal cord ependymomas.
Schüller U; Gocke A; Godbole S; Delbridge C; Thomas C; Neumann JE
Acta Neuropathol; 2024 May; 147(1):83. PubMed ID: 38735021
[No Abstract] [Full Text] [Related]
14. Re-evaluation of missense variant classifications in NF2.
Sadler KV; Rowlands CF; Smith PT; Hartley CL; Bowers NL; Roberts NY; Harris JL; Wallace AJ; Evans DG; Messiaen LM; Smith MJ
Hum Mutat; 2022 May; 43(5):643-654. PubMed ID: 35332608
[TBL] [Abstract][Full Text] [Related]
15. Mutation Profiling of Intracranial Myxopapillary Ependymoma by Next Generation DNA Sequencing.
Taher MM; Alhussini AA; Saeed M; Athar M; Bantan NAA; Jastania RA; Balkhoyour KB; Nageeti TH
Gulf J Oncolog; 2021 Sep; 1(37):7-16. PubMed ID: 35152189
[TBL] [Abstract][Full Text] [Related]
16. Interrogation of the microenvironmental landscape in spinal ependymomas reveals dual functions of tumor-associated macrophages.
Zhang Q; Cheng S; Wang Y; Wang M; Lu Y; Wen Z; Ge Y; Ma Q; Chen Y; Zhang Y; Cao R; Li M; Liu W; Wang B; Wu Q; Jia W; Wang X
Nat Commun; 2021 Nov; 12(1):6867. PubMed ID: 34824203
[TBL] [Abstract][Full Text] [Related]
17. Neurofibromatosis type 2 predisposes to ependymomas of various localization, histology, and molecular subtype.
Kresbach C; Dorostkar MM; Suwala AK; Wefers AK; Schweizer L; Engertsberger L; Bison B; Mynarek M; Kloth-Stachnau K; Spohn M; von Deimling A; Benesch M; Hagel C; Mautner VF; Rutkowski S; Schüller U
Acta Neuropathol; 2021 Jun; 141(6):971-974. PubMed ID: 33844070
[No Abstract] [Full Text] [Related]
18. Cystic meningioangiomatosis and cerebellar ependymoma in a child with neurofibromatosis type 2.
Wheeler A; Metrock K; Li R; Singh S
Radiol Case Rep; 2022 Apr; 17(4):1082-1087. PubMed ID: 35169405
[TBL] [Abstract][Full Text] [Related]
19. Pathological Classification of the Intramedullary Spinal Cord Tumors According to 2021 World Health Organization Classification of Central Nervous System Tumors, a Single-Institute Experience.
Park SH; Won JK; Kim CH; Phi JH; Kim SK; Choi SH; Chung CK
Neurospine; 2022 Sep; 19(3):780-791. PubMed ID: 36203303
[TBL] [Abstract][Full Text] [Related]
20. Evidence of an Inherited Predisposition for Spinal Cord Tumors.
Spiker WR; Brodke DS; Goz V; Lawrence B; Teerlink CC; Cannon-Albright LA
Global Spine J; 2018 Jun; 8(4):340-344. PubMed ID: 29977717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
